Contrast-enhanced ultrasound and clinical features for preoperative prediction of GPC-3 expression in hepatocellular carcinoma
Abdominal Radiology · 2026
DOI: 10.1007/s00261-026-05388-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2026. Verfasst von Qing Shu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Glypicans, Contrast Media. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Glypican 3 (GPC-3) in hepatocellular carcinoma (HCC) is receiving attention as a potential biomarker for treatment options. However, GPC-3 expression can only be assessed through surgical pathology. Therefore, we aim to develop and validate a practical tool based on contrast-enhanced ultrasound (CEUS) and clinical features to preoperatively identify GPC-3 expression in HCC. METHODS: From August 2021 to July 2024, 197 patients with pathologically confirmed HCC were retrospectively enrolled. The least absolute shrinkage and selection operator (LASSO) and stepwise logistic regression analyses were performed in training cohort to identify predictors and establish a model for predicting GPC-3 expression. The performance of model was evaluated by C-index, area under the receiver operating characteristic curve (ROC), calibration curves, and decision curve analysis (DCA). RESULTS: Our study showed that heterogeneous arterial phase hyperenhancement (APHE), mosaic architecture, alpha-fetoprotein (AFP) ≥ 100 ng/mL, rim enhancement in arterial phase (AP), neutrophil count (Nc) level and age were independently associated with GPC-3 expression. The model demonstrated strong predictive performance and the areas under curve were 0.811 (95% confidence interval[CI]: 0.737-0.885) and 0.750 (95%CI: 0.622-0.878) in training and validation cohorts. Good calibration and prominent net benefit were exhibited in both cohorts. Moreover, The risk score calculated by the model presented promising stratification ability between high-risk and low-risk groups in terms of relapse-free survival (RFS) . CONCLUSION: Based on CEUS and clinical features, the model can help identify GPC-3 expression accurately and may provide valuable preoperative insights for customizing personalized treatment planning in HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.
- Department of Interventional Ultrasound, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.
- Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China. dyuxl301@aliyun.com.
Zitieren
APA
Shu, Q., Pang, C., Wang, Z., Tian, X., Wang, S., Yan, X., Liang, P., Yu, J., & Yu, X. (2026). Contrast-enhanced ultrasound and clinical features for preoperative prediction of GPC-3 expression in hepatocellular carcinoma. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05388-2
Vancouver
Shu Q, Pang C, Wang Z, Tian X, Wang S, Yan X, et al. Contrast-enhanced ultrasound and clinical features for preoperative prediction of GPC-3 expression in hepatocellular carcinoma. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05388-2
BibTeX
@article{Shu2026,
author = {Shu, Qing and Pang, Chuan and Wang, Zhen and Tian, Xueqin and Wang, Shuo and Yan, Xizi and Liang, Ping and Yu, Jie and Yu, Xiaoling},
title = {Contrast-enhanced ultrasound and clinical features for preoperative prediction of GPC-3 expression in hepatocellular carcinoma},
journal = {Abdominal Radiology},
year = {2026},
doi = {10.1007/s00261-026-05388-2}
}
EUVIMED